It is our great pleasure to invite you to participate in the International Academy of Cardiology, Annual Scientific Sessions 2014, 19th World Congress on Heart Disease held in Boston, MA, USA on July 25 – 28, 2014.
The Congress will provide the opportunity for a comprehensive overview of the latest research developments in cardiovascular medicine, primarily in the areas of molecular biology, coronary artery disease, heart failure, cardiac arrhythmias and cardiac surgery.
Plans for this CME meeting are progressing extremely well. Many distinguished cardiologists and scientists have agreed to join the faculty participating in this Congress. Papers will be presented in the form of plenary sessions, symposia and posters, and will include superb scientific material originating from numerous laboratories around the globe, assuring that the meeting will be a major scientific event.
Program areas will range from clinical pathophysiology to evaluation and stratification techniques and molecular and cellular biology, including neurohumoral, immunological and genetic studies. We will discuss new and innovative diagnostic methods, prevention and treatment of heart disease, and prognostic algorithms. Integrated into the program will be an update on the latest major clinical trials.
We hope that you will participate in this Congress and submit for presentation your most recent scientific work in the rapidly evolving field of cardiovascular disease.
Your interaction with your colleagues from many different countries will stimulate a creative exchange of ideas and will be personally rewarding. We look forward to your active participation in the 19th World Congress on Heart Disease and to welcoming you to the beautiful city of Boston in July.
Molecular Cardiology, Basis Research
- Apoptosis in vascular and cardiac remodeling
- Oxidative stress and anti-oxidant therapy
- Genetic determinants of coronary heart disease
- Genetic studies in cardiomyopathy
- Gene transfer and therapy
- The pathogenesis of atherosclerosis
- Extracellular matrix and atherosclerosis
- Immunological principles in coronary artery disease
- Growth control and cytokines in vascular cells
- Neointimal hyperplasia and vascular injury
- Pharmacologic modulation of vascular-endothelial function
- Biochemical markers of acute ischemia
- Transesophageal echocardiography
- Pharmacologic stress testing — echocardiography
- Echocardiography, three-dimensional reconstruction
- Nuclear cardiology — new techniques to assess cardiac perfusion, function and viability
- PET — new insights into myocardial metabolism
- Applications of cardiac magnetic resonance imaging
- CT and coronary calcification
- Percutaneous coronary angioscopy
- Intravascular ultrasound imaging
- Intracoronary flow, doppler measurements
Coronary Artery Disease
- The plaque and acute coronary syndromes
- Mechanisms involved in myocardial stunning, hibernation and ischemic preconditioning
- Acute myocardial infarction: thrombolysis and reperfusion
- Angioplasty therapy for acute myocardial infarction
- Stents: new devices/optimal application/multiple stents
- Antithrombotic and antiplatelet adjunctive therapy for PTCA
- Blockade of tissue proliferation after coronary interventions
- Restenosis — use of ionizing radiation
- Nitrates, beta blockers, calcium entry blockers and ACE inhibition for myocardial ischemia/infarction
- Left ventricular remodeling after myocardial infarction
- Assessment of prognosis, post acute myocardial infarction
- Secondary prevention, risk stratification
- Cardiac rehabilitation as secondary prevention: is it worth the effort?
- Can the progress of atherosclerosis be halted?
- Modification of lipoproteins and coronary disease
- Hypertension, new therapeutic approaches
- Diabetes mellitus, obesity, insulin and atherosclerosis
- Mental stress: its effect on cardiovascular health
- Primary prevention of coronary artery disease in the healthy adult
- Hormone therapy in postmenopausal women: does it alter coronary risk?
- Prevention in children
- Neurohumoral, immunologic and cytokine aspects of heart failure
- Nitric oxide and nitric oxide synthase in heart failure
- Myocyte and receptor abnormalities in heart failure
- Natriuretic peptides, endothelin: role in heart failure
- Inflammatory mediators and heart failure
- Dilated cardiomyopathy: various etiologies
- Ischemic cardiomyopathy
- Left ventricular hypertrophy and hypertrophic cardiomyopathy
- Role of the pericardium, pericarditis and restrictive cardiomyopathy
- Pathophysiologic and prognostic insights in valvular heart disease
- Pulmonary circulation aspects, pulmonary hypertension
- Predictors and markers of heart failure outcome
- Exercise physiology in heart failure
- Renal aspects — diuretics
- Digoxin and other new inotropic agents in heart failure
- ACE inhibitors and Angiotensin-ll receptor blockers
- Beta-blockers and beta-adrenergic receptors in heart failure
- Calcium channel blockers and promoters in heart failure
- Cardiac pacing strategies in heart failure
- Arrhythmias and antiarrhythmic drug therapy
- Atrial flutter/fibrillation — electrophysiologic concepts and clinical aspects
- Management of cardiac arrhythmias pediatric population
- Heart rate variability and prognostic implications
- QT prolongation/dispersion: pathophysiology and prognostic implications
- Sudden death
- Electrophysiologic techniques of mapping and radiofrequency ablation
- Advances in internal defibrillation and implantable antiarrhythmic devices
- Cardiac Pacing
- Advances in congenital heart disease
- Angioplasty or surgery for multivessel coronary artery disease
- New approaches to surgical revascularization: Minimally invasive surgery, TMLR
- Therapeutic and physiologic issues surrounding heart valve surgery
- Mechanical support left ventricular assist devices
- Surgery for LV dysfunction
- Cardiac transplantation
Accepted abstracts of participants who have paid the Congress registration fees no later than June 5, 2014, will be published in a special online only supplement issue of the journal CARDIOLOGY. The journal CARDIOLOGY is published by S. Karger AG Medical and Scientific Publishers, Basel, Switzerland and the supplement issue will appear in CARDIOLOGY.
This publication will be registered at bibliographic services such as PubMed/Medline, Current Contents/Life Science, Journal Citation Reports/Science, EMBASE and Chemical Abstracts. Permission has been granted for Congress participants to print copies of the supplement and there is also free online access to this supplement issue.
In addition, the abstracts of the Congress will also be published in parallel in the JOURNAL OF HEART DISEASE (ISSN: 1556 – 7451), the official journal of the International Academy of Cardiology and will appear on our website.
International Academy of Cardiology Memorial Awards
The International Academy of Cardiology has established five awards to honor the memory of distinguished colleagues who made a major contribution to Medicine and Cardiology and who were members of the faculty for previous International Academy of Cardiology meetings. As in previous years, the recipients were selected by a very prestigious awards committee. The awards for 2014 will be presented at the opening ceremony of the congress.
International Academy of Cardiology Distinguished Fellowship Awards
The International Academy of Cardiology has established Distinguished Fellowship Awards, to honor colleagues who have made profound contributions to Cardiovascular Medicine and provided important service to the Academy. The Awards will be presented each year to faculty members of the World Congress on Heart Disease at the opening ceremony of the congress.
The scientific program of the 19th World Congress on Heart Disease will be reviewed by the American Medical Association for AMA PRA Category 1 Credit™.